WO1995009020A1 - Improvement in injection cartridges - Google Patents
Improvement in injection cartridges Download PDFInfo
- Publication number
- WO1995009020A1 WO1995009020A1 PCT/SE1994/000864 SE9400864W WO9509020A1 WO 1995009020 A1 WO1995009020 A1 WO 1995009020A1 SE 9400864 W SE9400864 W SE 9400864W WO 9509020 A1 WO9509020 A1 WO 9509020A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cartridge
- injection
- piston
- chamber
- liquid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/28—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
- A61M5/284—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle comprising means for injection of two or more media, e.g. by mixing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M2005/1787—Syringes for sequential delivery of fluids, e.g. first medicament and then flushing liquid
Definitions
- the present invention refers to an improvement in injection cartridges for administering parenteral injections or infusions. More particularly, the invention refers to an improve ⁇ ment in such injection cartridges which makes possible a better utilization of the injectable preparation used.
- the invention also refers to a method for administering a liquid preparation with the use of an injection cartridge of the invention. Furthermore, the invention also refers to the use of an injection cartridge of the invention for intravenous injection.
- An injection cartridge generally comprises a tubular barrel, which contains a liquid injectable preparation. At its front end, the barrel is sealed by a closure, which may be pierced by an outlet conduit, such as an injection needle or cannula or a tube for infusion. At its rear end, the cartridge is closed by a piston, which may be moved forward to expel the injectable preparation from the cartridge through the outlet conduit.
- This type of injection cartridge is known as a single-chamber injection cartridge.
- Dual-chamber injection cartridges are also well-known. Such cartridges are intended to be used for injectable preparations which are not stable in their ready-to-use state, and their space between the front closure and the rear piston is divided into two chambers, which are separated by a movable wall.
- the front chamber usually contains a solid component of the injectable preparation
- the rear chamber contains a liquid component of said preparation.
- a liquid bypass connection in the interior wall of the cartridge, such that the liquid component may bypass the movable separating wall and flow into the front chamber to be mixed with the solid component.
- US-A-4,439,184 discloses a two-dose syringe with a dual chamber, intended to provide two separate bodies of fluid in a sequence.
- a lubricating antiseptic and a lubricating anesthetic are used for preparing the urethra for catheteriza- tion.
- the lubricating properties of both the antiseptic and the anesthetic make it easier for the catheter to be slid into the urethra.
- an improvement in injection cartridges wherein a liquid preparation is expelled from the cartridge through an outlet conduit arranged at the front end of said cartridge by means of the displacement of a piston arranged in said cartridge.
- a liquid preparation is expelled from the cartridge through an outlet conduit arranged at the front end of said cartridge by means of the displacement of a piston arranged in said cartridge.
- the injection cartridge is a dual-chamber cartridge wherein a front chamber contains a solid component of the preparation, and a rear chamber contains a liquid component of the preparation, said chambers being separated by a displaceable separating wall, and wherein a rear liquid bypass connection is arranged in the interior wall of the cartridge, such that the liquid component may be caused to bypass said separating wall and flow into the front chamber to be mixed with the solid component, said rear chamber being closed at its rear end by said front piston, and the supplementary chamber for the rinsing liquid is arranged in said cartridge behind said front piston and is closed at its rear end by the rear movable piston.
- the volume of the rinsing liquid is at least twice the combined volume of any space in the cartridge in front of the front piston in its foremost position and the space in the outlet conduit.
- Figure 1 shows an injection cartridge according to the prior art before an injection is administered.
- Figure 2 shows an injection cartridge according to the prior art after an injection has been administered.
- Figure 3 shows an injection cartridge according to the invention before an injection is administered.
- Figure 4 shows an injection cartridge according to the invention after an injection has been administered, but before the rinsing step has started.
- Figure 5 shows an injection cartridge according to the invention during the rinsing step.
- Figure 6 shows an injection cartridge according to the invention after the rinsing step is finished.
- Figure 7 shows a dual-chamber injection cartridge according to the invention before it has been readied for injection.
- Figure 8 shows a dual-chamber injection cartridge according to the invention while it is being readied for injection.
- Figure 9 shows a dual-chamber injection cartridge according to the invention after the injectable preparation has been reconstituted in the front chamber.
- Figure 10 shows a dual-chamber injection cartridge according to the invention during an intermediate stage after the reconstitution of the injectable preparation.
- Figure 11 shows a dual-chamber injection cartridge according to the invention where the rinsing solution is flowing into the chamber formed behind the movable wall.
- Figure 12 shows a dual-chamber injection cartridge according to the invention which has been readied for the administration of an injection.
- Figure 13 shows a dual-chamber injection cartridge according to the invention during the administration of an injection.
- Figure 14 shows a dual-chamber injection cartridge according to the invention after finished administration of an injection, but before the rinsing step.
- Figure 15 shows a dual-chamber injection cartridge according to the invention after the rinsing step has been finished.
- FIG. 1 schematically shows a single-chamber injection cartridge according to the prior art where an administration of an injectable preparation has just started.
- the injection cartridge comprises a barrel 1, which is filled with a liquid injectable preparation 2.
- the chamber filled with this preparation 2 is sealed at its rear end by a piston 3.
- the cartridge is provided with an outlet conduit 4, and in the embodiment shown, this conduit is connected to a tube 5, which in its turn is connected to an injection needle or cannula 6.
- a device 7, such as a surgical adhesive tape for securing the needle 6 to the patient's skin.
- the administration of the injectable preparation 2 has just started, as is shown by the somewhat advanced position of the piston 3 and the drop of preparation shown at 8.
- Figure 2 shows the prior art cartridge after the administration has been finished.
- the piston 3 is at its foremost position in the barrel 1 and substantially all of the injectable preparation 2 has been expelled from the cartridge.
- this preparation 2 remaining in the dead volume provided by the outlet conduit 4 and the tube 5.
- This amount cannot be utilized by the patient and will usually be wasted.
- Such a waste may be quite important from an economical point of view when very expensive injectable preparations are administered, such as growth hormones and certain peptides.
- injectable preparations such as growth hormones and certain peptides.
- Figure 3 shows a single-chamber injection cartridge according to the present invention before an administration has started.
- the injection cartridge comprises a barrel 1 which contains a liquid injectable preparation 2, and the chamber containing this preparation is sealed at its rear end by a front piston 3.
- the cartridge is also provided with an outlet conduit 4, which is connected to an injection needle or cannula 6 via a tube 5.
- the barrel 1 is extended rearward and comprises a supplementary chamber which is filled with a rinsing liquid 9 and is sealed at its rear end by a rear piston 10. Furthermore, there is arranged a liquid bypass connection 11 near the front end of the cartridge.
- This bypass connection may be arranged in any of several ways well-known to those skilled in the art. For instance, it may consist of a channel arranged in the interior wall of the barrel 1 or of some other modification of the interior wall of the barrel.
- the liquid bypass connection may also be of the so-called "negative" type, wherein the interior of the cartridge is provided with a constriction such that the piston 3 will be deformed when it is in this position.
- the basic object to be fulfilled by the liquid bypass connection is that the piston 3 should not seal completely against said interior wall when it is in the position of said bypass connection.
- FIG. 4 shows the single-chamber injection cartridge according to the invention after essentially all of the injectable preparation has been expelled from the cartridge.
- the front piston 3 is in its foremost position in the barrel 1, but there is still a small amount of the injectable preparation 2 remaining in the dead volume afforded by the outlet conduit 4, the tube 5 and the liquid bypass connection 11.
- the front piston 3 is situated at the liquid bypass connection 11 in such a way that a liquid flow path is afforded from the chamber behind the front piston 3 around said front piston and into the dead space in front of it.
- FIG. 5 shows the single-chamber injection cartridge according to the invention after the rinsing step has started.
- the rear piston 10 has now been moved forward such that the rinsing liquid 9 has been made to flow through the liquid bypass connection 11 around the piston 3 and out into the dead volume afforded by the outlet conduit 4 and the tube 5, thereby expelling the injectable preparation previously present in this dead volume through the injection needle or cannula 6 into the patient.
- Figure 6 shows the single-chamber injection cartridge according to the invention after all of the rinsing liquid has been expelled from the cartridge.
- the rear piston is now abutting the front piston 3, and the outlet conduit 4 and the tube 5 contain substantially only the rinsing liquid 9.
- Substantially all of the injectable preparation has now been injected through the injection needle or cannula 6, together with a main portion of the rinsing liquid, as is illustrated by the drop 12.
- FIG. 7 shows a dual-chamber injection cartridge according to the invention.
- This cartridge comprises a tubular barrel 21, which is divided into a front chamber 22 and a rear chamber 23.
- the front chamber 22 contains the solid component 24 of an injectable preparation
- the rear chamber 23 contains the liquid component 25 of said injectable preparation.
- the front chamber 22 and the rear chamber 23 are separated by a sealing movable wall 26, and the rear chamber 23 is sealed at its rear end by the front piston 27.
- a liquid bypass connection 28 In the interior wall of the cartridge barrel 1 is arranged a liquid bypass connection 28.
- an outlet conduit 29 At the front end of the cartridge is arranged an outlet conduit 29 through which the injectable preparation may be expelled.
- the outlet conduit 29 is connected to an injection needle or cannula directly or via a tube, as shown in figures 1 to 6. For clarity, these details are not shown in figures 7 to 15.
- the barrel 21 of the injection cartridge of the present invention extends behind the front piston 27 to form a supplementary chamber 30.
- This chamber 30 is filled with a rinsing liquid 31 and is sealed at its rear end by a rear piston 32. Furthermore, a liquid bypass connection 33 is arranged at the front end of the cartridge.
- Figure 8 shows the dual-chamber injection cartridge according to the invention after the rear piston 32 has been moved forward so far that the movable wall 26 is situated at the position of the liquid bypass connection 28 and a portion of the liquid component 25 has been made to flow over from the rear chamber 23 into the front chamber 22.
- the liquid component 25 is mixed with the solid component 24 to dissolve it or suspend it, forming the ready-to-use injectable preparation.
- the rinsing liquid 31 is still enclosed in the supplementary chamber 30 between the front piston 27 and the rear piston 32.
- Figure 9 shows the dual-chamber injection cartridge according to the invention after all of the liquid component has been urged over into the front chamber 22, to form the injec ⁇ table preparation 34 together with the solid component.
- the front piston 27 now abuts the movable wall 26, and the rear chamber temporarily does not exist.
- the rear piston 32 and the front piston 27 the supplementary chamber 30 with the rinsing liquid 31 has been moved forward, but is otherwise unaffected.
- Figure 10 shows the dual-chamber injection cartridge according to the invention after the rear piston 32 and consequently also the front piston 27 and the movable wall 26 have been moved further forward so far that said front piston 27 and movable wall 26 cover the liquid bypass connection 28.
- This bypass connection 28 is therefore inactive at this stage.
- Figure 11 shows the dual-chamber injection cartridge according to the invention after the rear piston has been moved further forward such that the front piston 27 is at the position of the liquid bypass connection 28.
- the rinsing liquid 31 will start to flow around the front piston 27 and out into the space between the movable wall 26 and the front piston 27, thus recreating the rear chamber 23 and filling it with the rinsing liquid 31.
- the injectable preparation 34 in the front chamber 22 is also moved forward, but is otherwise unaffected.
- Figure 12 shows the dual-chamber injection cartridge according to the invention after all of the rinsing liquid 31 has been urged over into the rear chamber 23.
- the rear piston 32 now abuts the front piston 27, and these two pistons now act as one single piston, while the former supplementary chamber 30 has now disappeared.
- Figure 13 shows the dual-chamber injection cartridge according to the invention after the front and rear pistons 27 and 32, and consequently also the movable wall 26, have been advanced so far forward that the front chamber 22 is now filled completely with the injectable preparation 34. This preparation can now be expelled from the cartridge through the outlet conduit 29 to start the administration to a patient.
- the liquid bypass connection 28 is now inactive.
- Figure 14 shows the dual-chamber injection cartridge according to the invention after substantially all of the injectable preparation 34 has been expelled from the cartridge and administered to die patient. There is now a certain portion of said preparation remaining in the dead volume in the cartridge in front of the movable wall 26 and in the outlet conduit 29 and a possible tube (not shown) to an injection needle or cannula (not shown).
- the movable wall 34 When the movable wall 34 is in its foremost position, it is situated at the position of the front liquid bypass connection 33, which thereby becomes active and allows the rinsing liquid 31 to bypass said movable wall 34 and flow out in the dead volume in front of it.
- Figure 15 shows the dual-chamber injection cartridge according to the invention after all of the rinsing liquid has been expelled through the outlet conduit 29.
- the movable wall 26, the front piston 27 and the rear piston 32 now abut each other, and the liquid bypass connection 33 is inactive. The administration from the cartridge is now finished.
- the administration of the injectable preparation and subsequent rinsing from a single- chamber injection cartridge, as well as the readying, administration and rinsing from a dual-chamber injection cartridge according to the invention is carried out by urging the piston 3 (figures 3-6) or the rear piston 32 (figures 7-15) forward by means of a piston rod.
- a piston rod may be moved forward by simple axial forward pressure, by a screw mechanism, or by a combination of the two.
- Various arrangement for achieving this are well-known to those skilled in the art, and need not be described here in closer detail.
- the injection cartridge is usually supplied to the user in the state as shown and described in figure 7.
- the user applies forward pressure on the rear piston 32 by means of a suitable piston rod (not shown).
- This pressure is translated through the substantially incompressible liquids 25 and 31 in the rear chamber 23 and the rear end chamber 30, respectively, such that the movable wall 26 and the front piston 27 are also urged forward.
- the movable wall 26 has reached the position of the liquid bypass connection 28, this connection becomes active to allow a flow of the liquid component 25 around said movable wall 26 to become mixed with the solid component in the front chamber 22.
- the solid component 24 will then become dissolved or dispersed in the liquid component 25 to form the injectable preparation 34.
- the movable wall 26 will serve to expel the mixed injectable preparation 34 through the outlet conduit 29, which has been connected to an injection needle or cannula, optionally via a tube.
- the injection needle or cannula is now connected to a patient and the administration of said injectable preparation can now take place.
- the movable wall 26 After finished administration, the movable wall 26 is at its foremost position in the cartridge barrel 21, and substantially all of the injectable preparation has been expelled from the cartridge. However, there remains a certain portion of the preparation in the dead volume consisting of the space in front of the movable wall 26, the outlet conduit 29 and the attached tube and injection needle. This portion will not be utilized by the patient if no special measures are taken according to the invention.
- the movable wall 26 is positioned at the front liquid bypass connection 33 in such a way that a flow path for the rinsing liquid is provided around said movable wall.
- Further pressure forward on the combined pistons 27 and 32 will now make the rinsing liquid 31 flow around the movable wall 26 and out into the outlet conduit 29 and the attached tube and needle or cannula.
- the rinsing liquid 31 will displace the remaninder of the injectable preparation such that it is adminstered to the patient and the outlet conduit 29 and the tube are rinsed.
- the administration is finished.
- the injection cartridge is usually arranged in a holder device to facilitate its use in the administering of an injection.
- holder devices are also conventional and well-known to those skilled in the art.
- the injection cartridge according to the invention does not require any substantial design changes of the known holder devices. Small alterations may be necessary to accommodate the front bypass connection and the greater length of the cartridge, but these are within the competence of a person skilled in this art.
- the materials used for the manufacture of injection cartridges of the invention are the same as those used for conventional injection cartridges, such as glass and various plastic and rubber materials.
- the front piston may be made of any resilient material, preferably rubber.
- the movable wall between the front chamber and the rear chamber should be made of a resilient material with a low permeability for water vapour.
- a suitable material is butyl rubber, preferably a halo-butyl rubber, such as chlorobutyl or bromobutyl rubber.
- the barrel of the cartridge should be made of a rigid material, to better withstand the low pressure and themperature used in the lyophilization process.
- a suitable material is glass.
- the volume of the rinsing liquid is sufficient to effect a thorough rinsing of the dead volume and displace the remaining injectable preparation to inject it into the patient. It has been found that the volume of the rinsing liquid should be at least twice, and preferably at least three times the combined volume of the space in the injection cartridge in front of the front piston or the movable wall in its foremost position and the space in the outlet conduit to the injection needle or cannula. This gives a thorough rinsing effect.
- the injection cartridge of the invention can be used with any of those injectable prepara ⁇ tions that have been found to be suitable in conventional injection cartridges.
- therapeutic proteins and peptides As examples can be mentioned therapeutic proteins and peptides.
- the advantages offered by the invention become more pronounced when very expensive preparations are adminis ⁇ tered, suitably those produced by recombinant DNA technology.
- Typical examples are growth hormones, certain peptides, anticancer drugs, vaccines, interleukines, monoclonal antibodies, tissue plasmin activator (tPA), erythropoietin (EPO), urokinase, streptokinase, low molecular weight heparins and human proteins.
- the human proteins are factor VIII, factor IX or antithrombin III, produced by recombinant DNA technology. For such preparations, the avoidance of waste is of a great economic impor ⁇ tance.
- Suitable liquid injectable preparations include solutions containing human proteins, such as factor VIII, factor IX and antithrombin III, with at least one stabilizing agent, such as a surfactant.
- Suitable solid components of an injectable preparation include lyophilized human proteins, preferably factor VIII produced by recombinant DNA technology.
- the injection cartridge of the present invention is suitably used for parenteral admini ⁇ stration, such as subcutaneous, intramuscular or intravenous injection, preferably then intravenous injection. More preferably, the injection cartridge of the present invention is used for rinsing the outlet conduit connected to a tube and an injection needle or cannula from substantially all of the injectable preparation.
- the injection cartridge of the present invention is suitably used for the administering of any human protein, preferably then a lyophilized protein.
- the method for administering a liquid preparation from an injection syringe of the present invention is suitably used in parenteral administration, such as subcutaneous, intramuscu ⁇ lar or intravenous injection, preferably then intravenous injection. More preferably, the method for administering a liquid preparation is used for rinsing the outlet conduit connected to a tube and an injection needle or cannula from essentially all of the injectable preparation.
- the method for administering a liquid preparation from an injection cartridge of the present invention is suitably used for the administering of any human protein, preferably then a lyophilized protein.
- the rinsing liquid may be any liquid which is compatible with the injectable preparation and which does not cause any detrimental effects when administered to a patient.
- a number of such liquids are known to those skillled in the art, and as an example may be mentioned physiological saline solution.
Abstract
Description
Claims
Priority Applications (18)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019960701407A KR100346768B1 (en) | 1993-09-29 | 1994-09-16 | Improved Injection Cartridge |
RU96108258A RU2139736C1 (en) | 1993-09-29 | 1994-09-16 | Improvement of injection cartridges |
SK390-96A SK284232B6 (en) | 1993-09-29 | 1994-09-16 | Improvement in injection cartridges |
BR9407671A BR9407671A (en) | 1993-09-29 | 1994-09-16 | Injection cartridge process of administering a liquid preparation to a patient from an injection cartridge and using an injection cartridge |
CA002171632A CA2171632C (en) | 1993-09-29 | 1994-09-16 | Improvement in injection cartridges |
JP51024595A JP3670009B2 (en) | 1993-09-29 | 1994-09-16 | Injection cartridge |
DK94929067T DK0721357T3 (en) | 1993-09-29 | 1994-09-16 | Improvement in injection cartridges |
US08/619,634 US5772630A (en) | 1993-09-29 | 1994-09-16 | Injection cartridges |
EP94929067A EP0721357B1 (en) | 1993-09-29 | 1994-09-16 | Improvement in injection cartridges |
PL94313738A PL177284B1 (en) | 1993-09-29 | 1994-09-16 | Injecting container |
HU9600792A HU219112B (en) | 1993-09-29 | 1994-09-16 | Injection cartridges and method for injection from this |
RO96-00674A RO117761B1 (en) | 1993-09-29 | 1994-09-16 | Injection syringe |
AU78257/94A AU678611B2 (en) | 1993-09-29 | 1994-09-16 | Improvement in injection cartridges |
AT94929067T ATE214295T1 (en) | 1993-09-29 | 1994-09-16 | INJECTION CASSETTE |
DE69430131T DE69430131T2 (en) | 1993-09-29 | 1994-09-16 | INJECTION CARTRIDGE |
BG100450A BG62355B1 (en) | 1993-09-29 | 1996-03-25 | Multichamber syringe |
FI961408A FI114853B (en) | 1993-09-29 | 1996-03-28 | Improvement in injection cartridges |
NO19961264A NO312174B1 (en) | 1993-09-29 | 1996-03-28 | injection cartridge |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9303178A SE9303178D0 (en) | 1993-09-29 | 1993-09-29 | Improvements in injection cartridges |
SE9303178-9 | 1993-09-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1995009020A1 true WO1995009020A1 (en) | 1995-04-06 |
Family
ID=20391254
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/SE1994/000864 WO1995009020A1 (en) | 1993-09-29 | 1994-09-16 | Improvement in injection cartridges |
Country Status (27)
Country | Link |
---|---|
US (1) | US5772630A (en) |
EP (1) | EP0721357B1 (en) |
JP (1) | JP3670009B2 (en) |
KR (1) | KR100346768B1 (en) |
CN (1) | CN1126573C (en) |
AT (1) | ATE214295T1 (en) |
AU (1) | AU678611B2 (en) |
BG (1) | BG62355B1 (en) |
BR (1) | BR9407671A (en) |
CA (1) | CA2171632C (en) |
CZ (1) | CZ290946B6 (en) |
DE (1) | DE69430131T2 (en) |
DK (1) | DK0721357T3 (en) |
EE (1) | EE03236B1 (en) |
ES (1) | ES2173924T3 (en) |
FI (1) | FI114853B (en) |
HU (1) | HU219112B (en) |
NO (1) | NO312174B1 (en) |
NZ (1) | NZ274274A (en) |
PL (1) | PL177284B1 (en) |
PT (1) | PT721357E (en) |
RO (1) | RO117761B1 (en) |
RU (1) | RU2139736C1 (en) |
SE (1) | SE9303178D0 (en) |
SK (1) | SK284232B6 (en) |
WO (1) | WO1995009020A1 (en) |
ZA (1) | ZA947608B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5865798A (en) * | 1996-06-28 | 1999-02-02 | Becton Dickinson France, S.A. | Stopper assembly having bypass features for use in a multi-chamber syringe barrel |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL114960A0 (en) | 1995-03-20 | 1995-12-08 | Medimop Medical Projects Ltd | Flow control device |
US6423050B1 (en) * | 2000-06-16 | 2002-07-23 | Zbylut J. Twardowski | Method and apparatus for locking of central-vein catheters |
IL161660A0 (en) | 2004-04-29 | 2004-09-27 | Medimop Medical Projects Ltd | Liquid drug delivery device |
US8936577B2 (en) | 2005-05-02 | 2015-01-20 | Shi Zi Technology, Ltd. | Methods and devices for autoflush syringes |
US8529517B2 (en) * | 2005-05-02 | 2013-09-10 | Shi Zi Technology, Ltd. | Autoflush syringe |
US8075533B2 (en) * | 2005-05-02 | 2011-12-13 | Preventiv, Inc. | Autoflush syringe |
DK1919432T3 (en) | 2005-08-11 | 2012-01-30 | Medimop Medical Projects Ltd | Liquid Medication Transfer Devices for Safe Safe Resting Connection on Medical Vials |
IL182605A0 (en) | 2007-04-17 | 2007-07-24 | Medimop Medical Projects Ltd | Fluid control device with manually depressed actuator |
US8372043B2 (en) * | 2007-05-01 | 2013-02-12 | Geisinger Clinic | Devices and methods for fluid administration |
CN101918074B (en) * | 2007-09-18 | 2013-02-27 | 麦迪麦珀医疗工程有限公司 | Medicament mixing and injection apparatus |
IL186290A0 (en) | 2007-09-25 | 2008-01-20 | Medimop Medical Projects Ltd | Liquid drug delivery devices for use with syringe having widened distal tip |
EP2211948B1 (en) * | 2007-11-22 | 2018-12-12 | Swedish Orphan Biovitrum AB (publ) | A method and device for the serial ejection of two fluids comprising a spacer |
USD641080S1 (en) | 2009-03-31 | 2011-07-05 | Medimop Medical Projects Ltd. | Medical device having syringe port with locking mechanism |
USD630732S1 (en) | 2009-09-29 | 2011-01-11 | Medimop Medical Projects Ltd. | Vial adapter with female connector |
IL201323A0 (en) | 2009-10-01 | 2010-05-31 | Medimop Medical Projects Ltd | Fluid transfer device for assembling a vial with pre-attached female connector |
IL202069A0 (en) | 2009-11-12 | 2010-06-16 | Medimop Medical Projects Ltd | Fluid transfer device with sealing arrangement |
IL202070A0 (en) | 2009-11-12 | 2010-06-16 | Medimop Medical Projects Ltd | Inline liquid drug medical device |
BR112012021134B1 (en) | 2010-02-24 | 2020-01-21 | Medimop Medical Projects Ltd | fluid transfer set for use with a first vial and a second vial for reconstitution and liquid drug delivery |
CN102781396B (en) | 2010-02-24 | 2015-01-07 | 麦迪麦珀医疗工程有限公司 | Liquid drug transfer device with vented vial adapter |
USD669980S1 (en) | 2010-10-15 | 2012-10-30 | Medimop Medical Projects Ltd. | Vented vial adapter |
IL209290A0 (en) | 2010-11-14 | 2011-01-31 | Medimop Medical Projects Ltd | Inline liquid drug medical device having rotary flow control member |
IL212420A0 (en) | 2011-04-17 | 2011-06-30 | Medimop Medical Projects Ltd | Liquid drug transfer assembly |
IL215699A0 (en) | 2011-10-11 | 2011-12-29 | Medimop Medical Projects Ltd | Liquid drug reconstitution assemblage for use with iv bag and drug vial |
USD674088S1 (en) | 2012-02-13 | 2013-01-08 | Medimop Medical Projects Ltd. | Vial adapter |
USD737436S1 (en) | 2012-02-13 | 2015-08-25 | Medimop Medical Projects Ltd. | Liquid drug reconstitution assembly |
USD720451S1 (en) | 2012-02-13 | 2014-12-30 | Medimop Medical Projects Ltd. | Liquid drug transfer assembly |
IL219065A0 (en) | 2012-04-05 | 2012-07-31 | Medimop Medical Projects Ltd | Fluid transfer device with manual operated cartridge release arrangement |
IL221635A0 (en) | 2012-08-26 | 2012-12-31 | Medimop Medical Projects Ltd | Drug vial mixing and transfer device for use with iv bag and drug vial |
IL221634A0 (en) | 2012-08-26 | 2012-12-31 | Medimop Medical Projects Ltd | Universal drug vial adapter |
EP2872100B1 (en) | 2012-09-13 | 2017-03-29 | Medimop Medical Projects Ltd | Telescopic female drug vial adapter |
USD734868S1 (en) | 2012-11-27 | 2015-07-21 | Medimop Medical Projects Ltd. | Drug vial adapter with downwardly depending stopper |
IL225734A0 (en) | 2013-04-14 | 2013-09-30 | Medimop Medical Projects Ltd | Ready-to-use drug vial assemblages including drug vial and drug vial closure having fluid transfer member, and drug vial closure therefor |
JP6199483B2 (en) | 2013-05-10 | 2017-09-20 | メディモップ・メディカル・プロジェクツ・リミテッド | Medical device comprising a vial adapter having an in-line dry drug module |
USD767124S1 (en) | 2013-08-07 | 2016-09-20 | Medimop Medical Projects Ltd. | Liquid transfer device with integral vial adapter |
CN205626622U (en) | 2013-08-07 | 2016-10-12 | 麦迪麦珀医疗工程有限公司 | Liquid transfer device that is used together with infusion container |
USD765837S1 (en) | 2013-08-07 | 2016-09-06 | Medimop Medical Projects Ltd. | Liquid transfer device with integral vial adapter |
USD757933S1 (en) | 2014-09-11 | 2016-05-31 | Medimop Medical Projects Ltd. | Dual vial adapter assemblage |
ES2755473T3 (en) | 2014-12-08 | 2020-04-22 | Aspivix Sa | Gynecological apparatus and module |
WO2016110838A1 (en) | 2015-01-05 | 2016-07-14 | Medimop Medical Projects Ltd | Dual vial adapter assemblages with quick release drug vial adapter for ensuring correct usage |
JP6778255B2 (en) * | 2015-05-15 | 2020-10-28 | パルトゥラ メディカル,インコーポレーテッド | A device that protects the pelvic floor during vaginal delivery |
CN113143759B (en) | 2015-07-16 | 2024-01-30 | 西部制药服务以色列有限公司 | Liquid drug transfer device for secure telescopic snap-fit on an injection vial |
US11523843B2 (en) | 2015-08-21 | 2022-12-13 | Partura Medical, Inc. | Method of protecting the pelvic floor during vaginal childbirth |
USD801522S1 (en) | 2015-11-09 | 2017-10-31 | Medimop Medical Projects Ltd. | Fluid transfer assembly |
CN108366905A (en) | 2015-11-25 | 2018-08-03 | 西部制药服务以色列有限公司 | Include double bottle commutator components of the vial adapter of the inlet valve with automatic-sealed |
IL245800A0 (en) | 2016-05-24 | 2016-08-31 | West Pharma Services Il Ltd | Dual vial adapter assemblages including identical twin vial adapters |
IL245803A0 (en) | 2016-05-24 | 2016-08-31 | West Pharma Services Il Ltd | Dual vial adapter assemblages including vented drug vial adapter and vented liquid vial adapter |
IL246073A0 (en) | 2016-06-06 | 2016-08-31 | West Pharma Services Il Ltd | Fluid transfer devices for use with drug pump cartridge having slidable driving plunger |
IL247376A0 (en) | 2016-08-21 | 2016-12-29 | Medimop Medical Projects Ltd | Syringe assembly |
USD832430S1 (en) | 2016-11-15 | 2018-10-30 | West Pharma. Services IL, Ltd. | Dual vial adapter assemblage |
IL249408A0 (en) | 2016-12-06 | 2017-03-30 | Medimop Medical Projects Ltd | Liquid transfer device for use with infusion liquid container and pincers-like hand tool for use therewith for releasing intact drug vial therefrom |
IL251458A0 (en) | 2017-03-29 | 2017-06-29 | Medimop Medical Projects Ltd | User actuated liquid drug transfer devices for use in ready-to-use (rtu) liquid drug transfer assemblages |
IL254802A0 (en) | 2017-09-29 | 2017-12-31 | Medimop Medical Projects Ltd | Dual vial adapter assemblages with twin vented female vial adapters |
JP1630477S (en) | 2018-07-06 | 2019-05-07 | ||
USD923812S1 (en) | 2019-01-16 | 2021-06-29 | West Pharma. Services IL, Ltd. | Medication mixing apparatus |
JP1648075S (en) | 2019-01-17 | 2019-12-16 | ||
JP7101900B2 (en) | 2019-01-31 | 2022-07-15 | ウェスト・ファーマ・サービシーズ・アイエル・リミテッド | Liquid transfer device |
IL277446B2 (en) | 2019-04-30 | 2024-02-01 | West Pharma Services Il Ltd | Liquid transfer device with dual lumen iv spike |
USD956958S1 (en) | 2020-07-13 | 2022-07-05 | West Pharma. Services IL, Ltd. | Liquid transfer device |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4439184A (en) * | 1982-05-03 | 1984-03-27 | Concord Laboratories, Inc. | Two-dose syringe |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9202108D0 (en) * | 1992-07-07 | 1992-07-07 | Kabi Pharmacia Ab | DUAL-CHAMBER INJECTION CARTRIDGE |
WO1994012227A1 (en) * | 1992-12-01 | 1994-06-09 | Tetsuro Higashikawa | Syringe |
US5298024A (en) * | 1992-12-28 | 1994-03-29 | Frank Richmond | Multi-liquid medicament delivery system with reflex valves |
US5476449A (en) * | 1992-12-28 | 1995-12-19 | Richmond; Frank M. | Needleless multi-liquid medicament delivery system with membranes |
US5522804A (en) * | 1994-02-15 | 1996-06-04 | Lynn; Lawrence A. | Aspiration, mixing, and injection syringe |
-
1993
- 1993-09-29 SE SE9303178A patent/SE9303178D0/en unknown
-
1994
- 1994-09-16 BR BR9407671A patent/BR9407671A/en not_active IP Right Cessation
- 1994-09-16 CN CN94193582A patent/CN1126573C/en not_active Expired - Lifetime
- 1994-09-16 HU HU9600792A patent/HU219112B/en unknown
- 1994-09-16 DK DK94929067T patent/DK0721357T3/en active
- 1994-09-16 AT AT94929067T patent/ATE214295T1/en active
- 1994-09-16 JP JP51024595A patent/JP3670009B2/en not_active Expired - Lifetime
- 1994-09-16 CZ CZ1996893A patent/CZ290946B6/en not_active IP Right Cessation
- 1994-09-16 AU AU78257/94A patent/AU678611B2/en not_active Expired
- 1994-09-16 SK SK390-96A patent/SK284232B6/en not_active IP Right Cessation
- 1994-09-16 KR KR1019960701407A patent/KR100346768B1/en not_active IP Right Cessation
- 1994-09-16 RO RO96-00674A patent/RO117761B1/en unknown
- 1994-09-16 EP EP94929067A patent/EP0721357B1/en not_active Expired - Lifetime
- 1994-09-16 WO PCT/SE1994/000864 patent/WO1995009020A1/en active IP Right Grant
- 1994-09-16 PT PT94929067T patent/PT721357E/en unknown
- 1994-09-16 CA CA002171632A patent/CA2171632C/en not_active Expired - Lifetime
- 1994-09-16 ES ES94929067T patent/ES2173924T3/en not_active Expired - Lifetime
- 1994-09-16 DE DE69430131T patent/DE69430131T2/en not_active Expired - Lifetime
- 1994-09-16 NZ NZ274274A patent/NZ274274A/en not_active IP Right Cessation
- 1994-09-16 US US08/619,634 patent/US5772630A/en not_active Expired - Fee Related
- 1994-09-16 RU RU96108258A patent/RU2139736C1/en active
- 1994-09-16 PL PL94313738A patent/PL177284B1/en unknown
- 1994-09-29 ZA ZA947608A patent/ZA947608B/en unknown
- 1994-11-15 EE EE9400165A patent/EE03236B1/en unknown
-
1996
- 1996-03-25 BG BG100450A patent/BG62355B1/en unknown
- 1996-03-28 NO NO19961264A patent/NO312174B1/en not_active IP Right Cessation
- 1996-03-28 FI FI961408A patent/FI114853B/en not_active IP Right Cessation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4439184A (en) * | 1982-05-03 | 1984-03-27 | Concord Laboratories, Inc. | Two-dose syringe |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5865798A (en) * | 1996-06-28 | 1999-02-02 | Becton Dickinson France, S.A. | Stopper assembly having bypass features for use in a multi-chamber syringe barrel |
US5899881A (en) * | 1996-06-28 | 1999-05-04 | Grimard; Jean Pierre | Stopper assembly having bypass features for use in a multi-chamber syringe barrel |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU678611B2 (en) | Improvement in injection cartridges | |
JP3431629B2 (en) | Multi-chamber injection cartridge | |
US10898651B2 (en) | Syringes for prefilled and fill-at-use mixing and drug delivery | |
US4313440A (en) | Multipurpose double barrel syringe and method of manufacture of same | |
RU2134592C1 (en) | Device for controlled feed of liquids | |
AU559315B2 (en) | Disposable hypodermic syringe with deformable barrel | |
US20230128911A1 (en) | Multi chamber syringe unit and method of preparing a multi chamber syringe | |
JP3976635B2 (en) | Syringe for kit preparation, intermediate sliding valve for syringe-type kit preparation, syringe-type kit preparation, and X-ray contrast agent kit preparation | |
JP2004049668A (en) | Pre-filled syringe kit | |
CN111135392A (en) | Novel pre-assembled direct-connection double-needle cylinder for assisting premixing subcutaneous gel preparation | |
WO2011076852A2 (en) | Medical device with bypass arrangement | |
JP4114197B2 (en) | Prefilled syringe kit | |
JP3630329B6 (en) | Liquid controlled delivery device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 94193582.5 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU JP KE KG KP KR KZ LK LT LU LV MD MG MN MW NL NO NZ PL PT RO RU SD SE SI SK TJ TT UA US UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE MW SD AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1994929067 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 274274 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2171632 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 39096 Country of ref document: SK |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV1996-893 Country of ref document: CZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 08619634 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 961408 Country of ref document: FI Ref document number: 96-00674 Country of ref document: RO |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1994929067 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: PV1996-893 Country of ref document: CZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 1994929067 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: PV1996-893 Country of ref document: CZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 961408 Country of ref document: FI |